Invesco Pharmaceuticals ETF (NYSEARCA:PJP) Sees Significant Increase in Short Interest

Invesco Pharmaceuticals ETF (NYSEARCA:PJP) saw a large growth in short interest in the month of October. As of October 15th, there was short interest totaling 6,200 shares, a growth of 148.0% from the September 30th total of 2,500 shares. Based on an average daily trading volume, of 6,000 shares, the short-interest ratio is presently 1.0 days. Currently, 0.2% of the company’s shares are short sold. Currently, 0.2% of the company’s shares are short sold. Based on an average daily trading volume, of 6,000 shares, the short-interest ratio is presently 1.0 days.

Invesco Pharmaceuticals ETF Stock Performance

NYSEARCA:PJP opened at $96.92 on Friday. The stock’s fifty day moving average is $93.11 and its 200 day moving average is $85.73. Invesco Pharmaceuticals ETF has a fifty-two week low of $72.25 and a fifty-two week high of $96.94. The firm has a market capitalization of $277.19 million, a PE ratio of 15.59 and a beta of 0.50.

Institutional Trading of Invesco Pharmaceuticals ETF

Hedge funds and other institutional investors have recently bought and sold shares of the business. DHJJ Financial Advisors Ltd. purchased a new stake in Invesco Pharmaceuticals ETF in the second quarter worth $28,000. AE Wealth Management LLC increased its stake in Invesco Pharmaceuticals ETF by 21.5% in the second quarter. AE Wealth Management LLC now owns 717 shares of the company’s stock worth $57,000 after purchasing an additional 127 shares during the period. N.E.W. Advisory Services LLC purchased a new stake in Invesco Pharmaceuticals ETF in the first quarter worth $75,000. Focus Partners Advisor Solutions LLC purchased a new stake in Invesco Pharmaceuticals ETF in the first quarter worth $208,000. Finally, Jones Financial Companies Lllp increased its stake in Invesco Pharmaceuticals ETF by 11.6% in the first quarter. Jones Financial Companies Lllp now owns 2,428 shares of the company’s stock worth $210,000 after purchasing an additional 252 shares during the period.

About Invesco Pharmaceuticals ETF

PowerShares Dynamic Pharmaceuticals Portfolio (the Fund) is a non-diversified fund. The Fund seeks investment results that correspond generally to the price and yield of the Dynamic Pharmaceuticals Intellidex Index (the Index). The Index evaluates companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.